FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W9177793> ?p ?o ?g. }

• W9177793 endingPage "1455" @default.
• W9177793 startingPage "1447" @default.
• W9177793 abstract "The purpose of this study was to investigate the long-term outcome after elective percutaneous coronary intervention in low-risk patients screened for aspirin and/or clopidogrel responsiveness in the 3T/2R (Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel) trial.The impact of aspirin and/or clopidogrel poor response on long-term outcome is debated.Aspirin and clopidogrel response was measured with the VerifyNow system aspirin and P2Y12 assays. After percutaneous coronary intervention (PCI), death, stroke, and myocardial infarction were assessed up to 1 year.Overall, 1,277 patients were screened, and 826 (65%) were treated with PCI. In all, 124 patients were found to be aspirin poor responders, and there were 179 clopidogrel poor responders (totally, 278 poor responders). The 1-year end point was significantly higher in poor responders as compared to full responders (15.8% vs. 8.6%, p=0.002), which is principally due to more myocardial infarction occurrence. At multivariable analysis, clopidogrel poor response emerged as an independent predictor (hazard ratio: 1.15, 95% confidence interval: 1.03 to 1.28). Receiver-operator characteristic analysis identifies≤23 of percentage of platelet inhibition and ≥208 of P2Y12 reactivity units as optimal cut offs to predict 1-year end point. Excluding periprocedural events, also peri-PCI myocardial infarction, which is strongly related to aspirin/clopidogrel poor response, was an independent predictor (hazard ratio: 1.25, 95% confidence interval: 1.14 to 1.37). Glycoprotein IIb/IIIa inhibitor administration reduces this risk in poor responders (21.2% vs. 34.7%, p=0.02), but not in full responders (6.3% vs. 6.5%, p=0.8).Poor response to clopidogrel is an independent predictor of periprocedural myocardial infarction and worse 1-year outcome in low-risk patients undergoing PCI, whereas poor response to aspirin failed to predict a worse outcome. Contrary to what was observed in poor responders, glycoprotein IIb/IIa inhibitor therapy failed to provide a benefit in aspirin and/or clopidogrel full responders." @default.
• W9177793 created "2016-06-24" @default.
• W9177793 creator A5002977464 @default.
• W9177793 creator A5021824721 @default.
• W9177793 creator A5025673007 @default.
• W9177793 creator A5029034896 @default.
• W9177793 creator A5032028897 @default.
• W9177793 creator A5062655570 @default.
• W9177793 creator A5075033637 @default.
• W9177793 creator A5079151837 @default.
• W9177793 creator A5082002228 @default.
• W9177793 creator A5085784016 @default.
• W9177793 date "2010-10-01" @default.
• W9177793 modified "2023-10-17" @default.
• W9177793 title "Long-Term Clinical Outcome Based on Aspirin and Clopidogrel Responsiveness Status After Elective Percutaneous Coronary Intervention" @default.
• W9177793 cites W101302537 @default.
• W9177793 cites W125411024 @default.
• W9177793 cites W1409766979 @default.
• W9177793 cites W1575525639 @default.
• W9177793 cites W168371622 @default.
• W9177793 cites W1970493523 @default.
• W9177793 cites W1973914099 @default.
• W9177793 cites W1974655135 @default.
• W9177793 cites W1985684249 @default.
• W9177793 cites W1990031788 @default.
• W9177793 cites W1992621152 @default.
• W9177793 cites W2041392024 @default.
• W9177793 cites W2045934073 @default.
• W9177793 cites W2072386538 @default.
• W9177793 cites W2072518791 @default.
• W9177793 cites W2084673482 @default.
• W9177793 cites W2126830306 @default.
• W9177793 cites W2141883929 @default.
• W9177793 cites W2145126811 @default.
• W9177793 cites W2155991282 @default.
• W9177793 cites W2165620610 @default.
• W9177793 cites W2315642025 @default.
• W9177793 cites W4254850923 @default.
• W9177793 cites W4376848313 @default.
• W9177793 cites W67811773 @default.
• W9177793 doi "https://doi.org/10.1016/j.jacc.2010.03.103" @default.
• W9177793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20951320" @default.
• W9177793 hasPublicationYear "2010" @default.
• W9177793 type Work @default.
• W9177793 sameAs 9177793 @default.
• W9177793 citedByCount "115" @default.
• W9177793 countsByYear W91777932012 @default.
• W9177793 countsByYear W91777932013 @default.
• W9177793 countsByYear W91777932014 @default.
• W9177793 countsByYear W91777932015 @default.
• W9177793 countsByYear W91777932016 @default.
• W9177793 countsByYear W91777932017 @default.
• W9177793 countsByYear W91777932018 @default.
• W9177793 countsByYear W91777932019 @default.
• W9177793 countsByYear W91777932020 @default.
• W9177793 countsByYear W91777932021 @default.
• W9177793 countsByYear W91777932022 @default.
• W9177793 countsByYear W91777932023 @default.
• W9177793 crossrefType "journal-article" @default.
• W9177793 hasAuthorship W9177793A5002977464 @default.
• W9177793 hasAuthorship W9177793A5021824721 @default.
• W9177793 hasAuthorship W9177793A5025673007 @default.
• W9177793 hasAuthorship W9177793A5029034896 @default.
• W9177793 hasAuthorship W9177793A5032028897 @default.
• W9177793 hasAuthorship W9177793A5062655570 @default.
• W9177793 hasAuthorship W9177793A5075033637 @default.
• W9177793 hasAuthorship W9177793A5079151837 @default.
• W9177793 hasAuthorship W9177793A5082002228 @default.
• W9177793 hasAuthorship W9177793A5085784016 @default.
• W9177793 hasBestOaLocation W91777931 @default.
• W9177793 hasConcept C126322002 @default.
• W9177793 hasConcept C164705383 @default.
• W9177793 hasConcept C207103383 @default.
• W9177793 hasConcept C2776335557 @default.
• W9177793 hasConcept C2777628954 @default.
• W9177793 hasConcept C2777849778 @default.
• W9177793 hasConcept C2780400711 @default.
• W9177793 hasConcept C44249647 @default.
• W9177793 hasConcept C45393284 @default.
• W9177793 hasConcept C49059817 @default.
• W9177793 hasConcept C500558357 @default.
• W9177793 hasConcept C71924100 @default.
• W9177793 hasConceptScore W9177793C126322002 @default.
• W9177793 hasConceptScore W9177793C164705383 @default.
• W9177793 hasConceptScore W9177793C207103383 @default.
• W9177793 hasConceptScore W9177793C2776335557 @default.
• W9177793 hasConceptScore W9177793C2777628954 @default.
• W9177793 hasConceptScore W9177793C2777849778 @default.
• W9177793 hasConceptScore W9177793C2780400711 @default.
• W9177793 hasConceptScore W9177793C44249647 @default.
• W9177793 hasConceptScore W9177793C45393284 @default.
• W9177793 hasConceptScore W9177793C49059817 @default.
• W9177793 hasConceptScore W9177793C500558357 @default.
• W9177793 hasConceptScore W9177793C71924100 @default.
• W9177793 hasIssue "18" @default.
• W9177793 hasLocation W91777931 @default.
• W9177793 hasLocation W91777932 @default.
• W9177793 hasLocation W91777933 @default.

• next